Consensus statement: medical management of acromegaly

被引：167

作者：

Melmed, S

Casanueva, F

Cavagnini, F

Chanson, P

Frohman, LA

Gaillard, R

Ghigo, E

Ho, K

Jaquet, P

Kleinberg, D

Lamberts, S

Laws, E

Lombardi, G

Sheppard, MC

Thorner, M

Vance, ML

Wass, JAH

Giustina, A ^{[1
]}

机构：

[1] Univ Brescia, Spedali Civili, I-25125 Brescia, Italy

[2] Univ Calif Los Angeles, Sch Med, Cedar Sinai Res Inst, Los Angeles, CA USA

[3] Univ Santiago de Compostela, Santiago De Compostela, Spain

[4] Univ Milan, I-20122 Milan, Italy

[5] Hop Bicetre, Paris, France

[6] Univ Illinois, Chicago, IL USA

[7] Univ Hosp CHUV, Lausanne, Switzerland

[8] Univ Turin, I-10124 Turin, Italy

[9] Garvan Inst Med Res, Darlinghurst, NSW, Australia

[10] Univ Mediterranee, Marseille, France

[11] NYU Med Ctr, New York, NY 10016 USA

[12] Univ Rotterdam Hosp, Rotterdam, Netherlands

[13] Univ Virginia, Charlottesville, VA USA

[14] Sch Med, Naples, Italy

[15] Univ Birmingham, Birmingham B15 2TT, W Midlands, England

[16] Radcliffe Infirm, Oxford OX2 6HE, England

来源：

EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2005年 / 153卷 / 06期

关键词：

D O I：

10.1530/eje.1.02036

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In November 2003, the Pituitary Society and the European Neuroendocrine Association sponsored a consensus workshop in Seville to address challenging issues in the medical management of acromegaly. Participants comprised 70 endocrinologists and neurosurgeons with international expertise in managing patients with acromegaly. All participants participated in the workshop proceedings, and the final document written by the scientific committee reflects the consensus opinion of the interactive deliberations. The meeting was supported by an unrestricted educational grant from Ipsen. No pharmaceutical representatives participated in the program planning or in the scientific deliberations.

引用

页码：737 / 740

页数：4

共 8 条

[1] Long-term effects of lanreotide SR and octreotide LAR® on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly [J].

Amato, G ;

Mazziotti, G ;

Rotondi, M ;

Iorio, S ;

Doga, M ;

Sorvillo, F ;

Manganella, G ;

Di Salle, F ;

Giustina, A ;

Carella, C .

CLINICAL ENDOCRINOLOGY, 2002, 56 (01) :65-71

[2] Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: Predictive value of short-term results? [J].

Cozzi, R ;

Attanasio, R ;

Montini, M ;

Pagani, G ;

Lasio, G ;

Lodrini, S ;

Barausse, M ;

Albizzi, M ;

Dallabonzana, D ;

Pedroncelli, AM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3090-3098

[3] Criteria for cure of acromegaly: A consensus statement [J].

Giustina, A ;

Barkan, A ;

Casanueva, FF ;

Cavagnini, F ;

Frohman, L ;

Ho, K ;

Veldhuis, J ;

Wass, J ;

Von Werder, K ;

Melmed, S .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :526-529

[4] Diagnosis and treatment of acromegaly complications [J].

Giustina, A ;

Casanueva, FF ;

Cavagnini, F ;

Chanson, P ;

Clemmons, D ;

Frohman, LA ;

Gaillard, R ;

Ho, K ;

Jaquet, P ;

Kleinberg, DL ;

Lamberts, SWJ ;

Lombardi, G ;

Sheppard, M ;

Strasburger, CJ ;

Vance, ML ;

Wass, JAH ;

Melmed, S .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (12) :1242-1247

[5] Guidelines for acromegaly management [J].

Melmed, S ;

Casanueva, FF ;

Cavagnini, F ;

Chanson, P ;

Frohman, L ;

Grossman, A ;

Ho, K ;

Kleinberg, D ;

Lamberts, S ;

Laws, E ;

Lombardi, G ;

Vance, ML ;

Von Werder, K ;

Wass, J ;

Giustina, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) :4054-4058

[6] Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant [J].

Trainer, PJ ;

Drake, WM ;

Katznelson, L ;

Freda, PU ;

Herman-Bonert, V ;

van der Lely, AJ ;

Dimaraki, EV ;

Stewart, PM ;

Friend, KE ;

Vance, ML ;

Besser, GM ;

Scarlett, JA ;

Thorner, MO ;

Parkinson, C ;

Klibanski, A ;

Powell, JS ;

Barkan, AL ;

Sheppard, MC ;

Maldonado, M ;

Rose, DR ;

Clemmons, DR ;

Johannson, G ;

Bengtsson, BÅ ;

Stavrou, S ;

Kleinberg, DL ;

Cook, DM ;

Phillips, LS ;

Bidlingmaier, M ;

Strasburger, CJ ;

Hackett, S ;

Zib, K ;

Bennett, WF ;

Davis, RJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (16) :1171-1177

[7] Editorial: Acromegaly - Consensus, what consensus? [J].

Trainer, PJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3534-3536

[8] Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro [J].

Tulipano, G ;

Bonfanti, C ;

Milani, G ;

Billeci, B ;

Bollati, A ;

Cozzi, R ;

Maira, G ;

Murphy, WA ;

Poiesi, C ;

Turazzi, S ;

Giustina, A .

NEUROENDOCRINOLOGY, 2001, 73 (05) :344-351

← 1 →